Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial

J Ghosn; A-M Quinson; ND Sabo; L Cotte; C Piketty; N Dorléacq; M-L Bravo; D Mayers; J Harmenberg; G Mårdh; H Valdez; C Katlama

doi:10.1111/j.1468-1293.2007.00444.x

Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial

HIV Medicine ◽

10.1111/j.1468-1293.2007.00444.x ◽

2007 ◽

Vol 8 (3) ◽

pp. 142-147 ◽

Cited By ~ 10

Author(s):

J Ghosn ◽

A-M Quinson ◽

ND Sabo ◽

L Cotte ◽

C Piketty ◽

...

Keyword(s):

Antiviral Activity ◽

Low Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717967956.793467610 ◽

2012 ◽

Author(s):

Robin Steinhorn

Keyword(s):

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Sildenafil Citrate ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Dose Ranging ◽

Pulmonary Arterial

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail

British Journal of Dermatology ◽

10.1111/bjd.19224 ◽

2020 ◽

Cited By ~ 1

Author(s):

B. Elewski ◽

S. Brand ◽

T. Degenhardt ◽

S. Curelop ◽

R. Pollak ◽

...

Keyword(s):

Phase Ii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text

Effect of low-dose human atrial natriuretic peptide on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer: A double-blind, placebo-controlled study

Journal of Thoracic and Cardiovascular Surgery ◽

10.1016/j.jtcvs.2011.09.003 ◽

2012 ◽

Vol 143 (2) ◽

pp. 488-494 ◽

Cited By ~ 21

Author(s):

Takashi Nojiri ◽

Kazuhiro Yamamoto ◽

Hajime Maeda ◽

Yukiyasu Takeuchi ◽

Yasunobu Funakoshi ◽

...

Keyword(s):

Lung Cancer ◽

Atrial Fibrillation ◽

Atrial Natriuretic Peptide ◽

Natriuretic Peptide ◽

Low Dose ◽

Pulmonary Resection ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Human Atrial Natriuretic Peptide

Download Full-text

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

BMJ ◽

10.1136/bmj.328.7441.686-b ◽

2004 ◽

Vol 328 (7441) ◽

pp. 686.3

Keyword(s):

Type 2 Diabetes ◽

Low Dose ◽

Controlled Trial ◽

Urinary Albumin ◽

Double Blind ◽

Double Blind Placebo ◽

Renal Outcomes

Download Full-text

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

The Lancet Neurology ◽

10.1016/s1474-4422(08)70173-x ◽

2008 ◽

Vol 7 (9) ◽

pp. 796-804 ◽

Cited By ~ 326

Author(s):

Benjamin M Segal ◽

Cris S Constantinescu ◽

Aparna Raychaudhuri ◽

Lilianne Kim ◽

Rosanne Fidelus-Gort ◽

...

Keyword(s):

Multiple Sclerosis ◽

Phase Ii ◽

Double Blind ◽

Subcutaneous Injections ◽

Double Blind Placebo ◽

Relapsing Remitting ◽

Dose Ranging ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

The Lancet ◽

10.1016/s0140-6736(16)30307-5 ◽

2016 ◽

Vol 388 (10039) ◽

pp. 31-44 ◽

Cited By ~ 446

Author(s):

Sally Wenzel ◽

Mario Castro ◽

Jonathan Corren ◽

Jorge Maspero ◽

Lin Wang ◽

...

Keyword(s):

Inhaled Corticosteroids ◽

Persistent Asthma ◽

High Dose ◽

Efficacy And Safety ◽

Pivotal Phase ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging ◽

Long Acting ◽

Β2 Agonist

Download Full-text

ADDING LOW-DOSE CYCLOSPORIN A TO PARENTERAL GOLD THERAPY IN RHEUMATOID ARTHRITIS: A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

Rheumatology ◽

10.1093/rheumatology/35.11.1142 ◽

1995 ◽

Vol 35 (11) ◽

pp. 1142-1149 ◽

Cited By ~ 13

Author(s):

G. BENDEX ◽

A. BJELLE

Keyword(s):

Rheumatoid Arthritis ◽

Cyclosporin A ◽

Low Dose ◽

Controlled Study ◽

Double Blind ◽

Gold Therapy ◽

Double Blind Placebo

Download Full-text

Exploring the potential of low-dose sulfasalazine in stable coronary artery disease patients: randomized, double-blind, placebo-controlled study

European Heart Journal - Cardiovascular Pharmacotherapy ◽

10.1093/ehjcvp/pvv021 ◽

2015 ◽

Vol 1 (4) ◽

pp. 214-216 ◽

Cited By ~ 3

Author(s):

Kanchan Vohra ◽

Pawan Krishan ◽

Sudhir Varma ◽

Harpreet Singh Kalra

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Low Dose ◽

Stable Coronary Artery Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Artery Disease

Download Full-text

A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy

Journal of Psychopharmacology ◽

10.1177/0269881117722998 ◽

2017 ◽

Vol 31 (9) ◽

pp. 1190-1203 ◽

Cited By ~ 5

Author(s):

Cynthia Richards ◽

Dan V Iosifescu ◽

Rajnish Mago ◽

Elias Sarkis ◽

James Reynolds ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Antidepressant Therapy ◽

Inadequate Response ◽

Major Depressive ◽

Lisdexamfetamine Dimesylate ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text